T. Rowe Price Associates
STIM icon

T. Rowe Price Associates’s Neuronetics STIM Stock Holding History

T. Rowe Price Associates’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54K Hold
36,861
– – ﹤0.01% 3069
2025
Q4 		$51K Hold
36,861
– – ﹤0.01% 3030
2025
Q3 		$101K Hold
36,861
– – ﹤0.01% 2926
2025
Q2 		$129K Buy
36,861
+17,761
+93% +$70.1K ﹤0.01% 2841
2025
Q1 		$71K Hold
19,100
– – ﹤0.01% 2883
2024
Q4 		$31K Hold
19,100
– – ﹤0.01% 2976
2024
Q3 		$15K Hold
19,100
– – ﹤0.01% 2996
2024
Q2 		$35K Hold
19,100
– – ﹤0.01% 2889
2024
Q1 		$91K Hold
19,100
– – ﹤0.01% 2799
2023
Q4 		$56K Hold
19,100
– – ﹤0.01% 2794
2023
Q3 		$26K Hold
19,100
– – ﹤0.01% 2840
2023
Q2 		$42K Hold
19,100
– – ﹤0.01% 2821
2023
Q1 		$56K Hold
19,100
– – ﹤0.01% 2779
2022
Q4 		$131K Hold
19,100
– – ﹤0.01% 2656
2022
Q3 		$61K Buy
19,100
+7,600
+66% +$27.6K ﹤0.01% 2806
2022
Q2 		$37K Sell
11,500
-2,313
-17% -$6.71K ﹤0.01% 2894
2022
Q1 		$42K Buy
+13,813
New +$46.7K ﹤0.01% 2935
2021
Q4 		– Sell
-18,913
Closed -$124K – 3038
2021
Q3 		$124K Buy
18,913
+6,200
+49% +$59.5K ﹤0.01% 2806
2021
Q2 		$204K Buy
12,713
+1,913
+18% +$26.4K ﹤0.01% 2726
2021
Q1 		$134K Buy
+10,800
New +$166K ﹤0.01% 2758
2018
Q4 		– Sell
-231,386
Closed -$7.42M – 2592
2018
Q3 		$7.42M Sell
231,386
-45,514
-16% -$1.38M ﹤0.01% 1416
2018
Q2 		$7.37M Buy
+276,900
New +$7.53M ﹤0.01% 1397

Other funds holding STIM

MAM
Madryn Asset Management New York $34.1M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates's STIM Position: Q1 2026 in Review

T. Rowe Price Associates held its Neuronetics (STIM) position steady in Q1 2026 at 36,861 shares worth $54K. The position accounts for ﹤0.01% of the portfolio, ranked #3069.

T. Rowe Price Associates first reported a position in STIM in Q2 2018 and has held it in 22 quarters since. The position peaked at $7.42M in Q3 2018. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • T. Rowe Price Associates held 36,861 shares of Neuronetics worth $54K as of Q1 2026.
  • T. Rowe Price Associates left its Neuronetics share count unchanged in Q1 2026.
  • Neuronetics made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #3069 holding.
  • T. Rowe Price Associates first reported a position in Neuronetics in Q2 2018 and has held it in 22 quarters since.
  • T. Rowe Price Associates's Neuronetics position peaked at $7.42M in Q3 2018.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.